Inmune Bio(DE:0Y2)
€1.390.00 (0.00%)
DE:0Y2
Inmune Bio earnings date
€1.39
At close:0.00 (0.00%)
Inmune Bio (0Y2) Q2 2021 Earnings Report
0 Followers
DE:0Y2 Q2 2021 EPS Results
- Actual EPS
- -EUR 0.39
- Consensus EPS
- -EUR 0.30
- Beat/Miss
- Missed by -EUR 0.09
- One Year Ago EPS
- -EUR 0.18
DE:0Y2 Q2 2021 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/04/2021
- Time
- After Close
- Conference Call
- Wednesday, August 4, 2021
DE:0Y2 Upcoming Earnings
Inmune Bio's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:0Y2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.19- | -0.18 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.13-0.15 | -0.21 | 29.17% (+0.06) | |
| Aug 06, 2026 | 2026 (Q2) | -0.19-0.04 | -0.94 | 95.24% (+0.90) | |
| May 07, 2026 | 2026 (Q1) | -0.22-0.18 | -0.39 | 53.49% (+0.21) | |
| Mar 30, 2026 | 2025 (Q4) | -0.24-0.18 | -0.36 | 50.50% (+0.18) | |
| Oct 30, 2025 | 2025 (Q3) | -0.28-0.21 | -0.54 | 60.00% (+0.32) | |
| Aug 07, 2025 | 2025 (Q2) | -0.34-0.94 | -0.45 | -110.00% (-0.49) | |
| May 08, 2025 | 2025 (Q1) | -0.42-0.39 | -0.55 | 29.51% (+0.16) | |
| Mar 27, 2025 | 2024 (Q4) | -0.49-0.36 | -0.42 | 14.89% (+0.06) | |
| Oct 31, 2024 | 2024 (Q3) | -0.45-0.54 | -0.43 | -25.00% (-0.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
